AU Stock MarketDetailed Quotes

ACL Australian Clinical Labs Ltd

Watchlist
  • 2.280
  • -0.010-0.44%
20min DelayNot Open Jun 3 16:00 AET
460.18MMarket Cap12.74P/E (Static)

Australian Clinical Labs Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
Operating cash flow (direct method)
Cash income from operating activities
-27.42%718.73M
49.59%990.24M
661.97M
Revenue from customers
-27.42%718.73M
49.59%990.24M
--661.97M
Cash paid
13.17%-543.47M
-39.03%-625.93M
-450.22M
Payments to suppliers for goods and services
13.17%-543.47M
-39.03%-625.93M
---450.22M
Direct interest paid
-21.55%-13.85M
71.08%-11.39M
---39.39M
Direct interest received
304.44%182K
-40.00%45K
--75K
Direct tax refund paid
74.00%-17.91M
-271.00%-68.87M
---18.56M
Operating cash flow
-49.42%143.68M
84.64%284.09M
--153.86M
Investing cash flow
Cash flow from continuing investing activities
83.09%-12.18M
-1,085.70%-72.04M
-6.08M
Net PPE purchase and sale
68.07%-6.7M
-123.32%-20.98M
---9.39M
Net investment purchase and sale
----
----
--1.07M
Net other investing changes
89.26%-5.48M
-2,367.50%-51.06M
--2.25M
Cash from discontinued investing activities
Investing cash flow
83.09%-12.18M
-1,085.70%-72.04M
---6.08M
Financing cash flow
Cash flow from continuing financing activities
37.59%-137.88M
-49.90%-220.91M
-147.37M
Net issuance payments of debt
166.00%66M
-292.27%-100M
--52.01M
Net common stock issuance
81.98%-891K
-103.38%-4.94M
--146.25M
Cash dividends paid
-299.03%-96.88M
42.19%-24.28M
---42M
Net other financing activities
-15.73%-106.11M
69.80%-91.69M
---303.63M
Cash from discontinued financing activities
Financing cash flow
37.59%-137.88M
-49.90%-220.91M
---147.37M
Net cash flow
Beginning cash position
-25.15%26.37M
1.10%35.23M
--34.85M
Current changes in cash
28.07%-6.38M
-2,221.05%-8.87M
--418K
Effect of exchange rate changes
-900.00%-40K
114.71%5K
---34K
End cash Position
-24.33%19.96M
-25.15%26.37M
--35.23M
Free cash from
-47.97%136.75M
82.07%262.84M
--144.36M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021
Operating cash flow (direct method)
Cash income from operating activities -27.42%718.73M49.59%990.24M661.97M
Revenue from customers -27.42%718.73M49.59%990.24M--661.97M
Cash paid 13.17%-543.47M-39.03%-625.93M-450.22M
Payments to suppliers for goods and services 13.17%-543.47M-39.03%-625.93M---450.22M
Direct interest paid -21.55%-13.85M71.08%-11.39M---39.39M
Direct interest received 304.44%182K-40.00%45K--75K
Direct tax refund paid 74.00%-17.91M-271.00%-68.87M---18.56M
Operating cash flow -49.42%143.68M84.64%284.09M--153.86M
Investing cash flow
Cash flow from continuing investing activities 83.09%-12.18M-1,085.70%-72.04M-6.08M
Net PPE purchase and sale 68.07%-6.7M-123.32%-20.98M---9.39M
Net investment purchase and sale ----------1.07M
Net other investing changes 89.26%-5.48M-2,367.50%-51.06M--2.25M
Cash from discontinued investing activities
Investing cash flow 83.09%-12.18M-1,085.70%-72.04M---6.08M
Financing cash flow
Cash flow from continuing financing activities 37.59%-137.88M-49.90%-220.91M-147.37M
Net issuance payments of debt 166.00%66M-292.27%-100M--52.01M
Net common stock issuance 81.98%-891K-103.38%-4.94M--146.25M
Cash dividends paid -299.03%-96.88M42.19%-24.28M---42M
Net other financing activities -15.73%-106.11M69.80%-91.69M---303.63M
Cash from discontinued financing activities
Financing cash flow 37.59%-137.88M-49.90%-220.91M---147.37M
Net cash flow
Beginning cash position -25.15%26.37M1.10%35.23M--34.85M
Current changes in cash 28.07%-6.38M-2,221.05%-8.87M--418K
Effect of exchange rate changes -900.00%-40K114.71%5K---34K
End cash Position -24.33%19.96M-25.15%26.37M--35.23M
Free cash from -47.97%136.75M82.07%262.84M--144.36M
Accounting Standards US-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg